Medtronic’s Q1 2022 results, J&J CEO to step down & more: 4 device company notes

Medtronic’s 23 percent increase in quarterly revenue and three more updates from spine and orthopedic device companies in the last week:

Advertisement

1. Medtronic posted its financial results for the first quarter of fiscal year 2022 on Aug. 24. Read more here.

2. Shoulder Innovation’s InSet reverse shoulder arthroplasty system received FDA 510(k) clearance.

3. Alex Gorsky will step down as chair and CEO of Johnson & Johnson and serve as executive chairman effective Jan. 3, 2022.

4. Here are eight things to know about Joaquin Duato, who will succeed Mr. Gorsky as Johnson & Johnson’s CEO.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.